SCHEMBL19845296

SCHEMBL19845296

c1ccc(-c2cccc(-c3cccc(-c4cc(-c5cccc(-n6c7ccc(-c8ccc9c(c8)c8ccccc8n9-c8ccccc8)cc7c7cc(-c8ccc9c(c8)c8ccccc8n9-c8ccccc8)ccc76)c5)nc(-n5c6ccc(-c7ccc8c(c7)c7ccccc7n8-c7ccccc7)cc6c6cc(-c7ccc8c(c7)c7ccccc7n8-c7ccccc7)ccc65)n4)c3)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ATM Q13315 1/20 0.44
PTGER4 P35408 1/20 0.36
TSPO P30536 1/20 0.36
PDE10A Q9Y233 1/20 0.34
PTGES O14684 1/20 0.34
NPY5R Q15761 1/20 0.34
KMT2A Q03164 3/20 0.33
IL1R1 P14778 1/20 0.33
HDAC4 P56524 1/20 0.33
MEN1 O00255 2/20 0.33
TET2 Q6N021 1/20 0.33
TET1 Q8NFU7 1/20 0.33
GAA P10253 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
RXFP1 Q9HBX9 1/20 0.32
TUBB4A P04350 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19845330 1.00 L3MBTL1 (0.44) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL17904190 1.00 L3MBTL1 (0.44) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL18213908 1.00 L3MBTL1 (0.44) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL19845341 1.00 L3MBTL1 (0.44) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL19845306 1.00 L3MBTL1 (0.44) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL19845324 0.99 L3MBTL1 (0.43) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL19845319 0.99 L3MBTL1 (0.43) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL17904189 0.99 L3MBTL1 (0.43) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL18214155 0.98 KDM4E (0.44) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL19845698 0.98 KDM4E (0.41) L3MBTL1KDM4EATMPTGER4TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180037574-A1 COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-02-08 US disclosed
US-20180037574-A1 COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180037574-A1 COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE PIEZO1, ETV6, LEF1 L3MBTL1 3274/4885KDM4E 2538/4885ATM 3035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.